CTOs on the Move

Express Scripts

www.express-scripts.com

 
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science℠, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Robert Tighe
 Business Information Security Officer Profile
Erick Rudiak
 Chief Information Security Officer Profile
Mike Green
 Deputy Chief Information Security Officer and Senior Director Information Risk Management Profile
Neal Sample
 Executive Vice President and Chief Operations Officer Profile

Similar Companies

Loretto

Loretto is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INFOHEALTH Management

INFOHEALTH Management Corp. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SecureAlert

SecureAlert, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. SecureAlert, Inc is based in Sandy, UT. You can find more information on SecureAlert, Inc at www.remotemdx.com

Scynexis

SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.

TruVision

TruVision is a South Jordan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.